Optimizing physical performance is a major goal in current physiology. However, basic understanding of combining high sprint and endurance performance is currently lacking. This study identifies critical determinants of combined sprint and endurance performance using multiple regression analyses of physiological determinants at different biological levels. Twenty-eight cyclists (24 (inter)national sprint, team pursuit and road cyclists) completed a Wingate test and 15-km time trial to obtain sprint and endurance performance, respectively. Performance was normalized to lean body mass 2/3 to eliminate the influence of body size. Performance determinants were obtained from whole-body oxygen consumption, blood sampling, knee-extensor maximal force, muscle oxygenation, whole-muscle morphology and muscle fiber histochemistry of m. vastus lateralis. Normalized sprint performance was explained by percentage fast type fibers and muscle volume (R 2 =0.65 p<0.001) and normalized endurance performance by performance V O 2 , mean corpuscular hemoglobin concentration and muscle oxygenation (R 2 =0.92 p<0.001). Combined sprint and endurance performance was explained by gross efficiency, performance V O 2 and likely by muscle volume and fascicle length (p=0.056 and p=0.059, respectively). High performance V O 2 related to a high oxidative capacity, high capillarization•myoglobin and small physiological cross-sectional area (R 2 =0.67 p<0.001). Results suggest that fascicle length and capillarization are important targets for training to optimize sprint and endurance performance simultaneously.
Introduction
Many sports require a combination of sprint and endurance performance. Over the last decades, physiological determinants of physical performance have been subject of intensive investigation (e.g. in cycling, Ref [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] ). Studies focused on determinants of either sprint (e.g. Ref [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ) or endurance performance (e.g. Ref [1] [2] [3] [4] [5] [6] [7] [19] [20] [21] [22] [23] ), even though physical performance is rarely a dichotomous function of only sprint or endurance. Generally, a limited number of whole-body determinants of sprint or endurance performance have been studied, while there are many physical performance determinants at different levels (i.e. molecular, cellular, whole-muscle, organ and whole-body), which may interact. This increases the complexity of maximizing performance, and increases complexity of physiological adaptations in response to training and/or nutritional interventions. So far, most research has addressed determinants of physical performance at the organ or whole-body level (e.g. in cycling, Ref [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] ). Another factor that adds to the complexity of optimizing physical performance is that adaptations for endurance or peak power are mutually exclusive, particularly in skeletal muscle [24] [25] [26] . Prime determinants of physical performance in humans are skeletal muscle endurance and maximal power generating capacity 25, 27 . Muscle peak power is largely determined by the myosin heavy chain isoform expression and muscle volume (e.g. Ref 11, 12, [16] [17] [18] [28] [29] [30] [31] ), whereas (muscle) endurance capacity relies on mitochondrial oxidative capacity and oxygen supply towards and within the muscle (e.g. Ref 1, [20] [21] [22] 27, [32] [33] [34] ). It is, however, generally acknowledged that muscle fiber size and oxidative capacity are inversely related 25, 35 . Apparently, these are adapted such that oxygen demand and supply are matched and that muscle fibers prevent hypoxia at V O 2max 25, 36 . Increasing both fiber size and oxidative capacity is commonly endeavoured in sports and rehabilitation training, but with limited success 24 . Moreover, molecular signaling pathways for mitochondrial biogenesis inhibit contractile muscle protein synthesis [24] [25] [26] . Improving both traits simultaneously is therefore highly challenging. It has been postulated that to increase both fiber size and oxidative capacity, one should enhance oxygen supply towards and within the muscle fibers 25 . This should accommodate the increased oxygen diffusion distance from capillaries to the mitochondria resulting from increases in fiber size 25 . Given the interference between determinants for peak power and endurance performance, the question arises how to improve both traits simultaneously.
An integrative approach assessing how physiological determinants are related to performance of top-level athletes may provide new insights in the key determinants and the most optimal combination of determinants for (combined) sprint and endurance performance. For this purpose, we assessed the critical determinants of sprint, endurance, and combined sprint and endurance performance in athletes using explained variance by correlation and multiple regression analyses. We assessed sprint performance by peak power production and the following determinants: muscle fiber size, muscle fiber type, number of muscle fibers and whole-muscle morphology of m. vastus lateralis (VL), blood lactate concentration, maximal isometric torque and specific force. Endurance performance was assessed during a time trial with determinants: muscle fiber oxidative capacity, muscle fiber type, oxygen supply towards muscle fiber (reflected by capillaries and blood parameters) and within the muscle fiber (myoglobin concentration), whole-muscle oxygenation of VL, blood lactate concentration, whole-body oxygen consumption, and mechanical gross efficiency. Maximal power of an organism is scaled to its body size. To eliminate effects of body size and investigate only biological differences in power production, physical performance was normalized to lean body mass 37 . Cross-sectional studies among cyclists are likely a useful model to investigate critical determinants of (combined) sprint and endurance performance, as cycling disciplines focus on either optimization of sprint, endurance or on both sprint and endurance 38 .
We assessed determinants of combined sprint and endurance performance in sprint, team pursuit and road cyclists, as these cyclists were expected to have optimized physical performance within their respective cycling discipline.
Materials and Methods

Subjects
Twenty-eight cyclists (14 road, 8 team pursuit and 6 track sprint cyclists) were included in the study. Cyclists (age 25 ± 7 years, weight 77.4 ± 8.1 kg, height 1.86 ± 0.06 m, BMI 22.4 ± 1.9, lean body mass 68.8 ± 6.0 kg, V O 2max 62.7 ± 7.9 mL•kg -1 •min -1
, as described previously in Ref 34 ) competed at the national, international or Olympic level, except for 4 amateur road cyclists. The study was conducted according to the Declaration of Helsinki (2013) and was approved by the VUmc Ethics Committee, Amsterdam, The Netherlands (NL49060.029.14). Subjects provided written informed consent and were instructed to avoid strenuous exercise and alcohol consumption (<24 h) and to consume no meals and caffeinated beverages (<3 h) before exercise testing. Training specifics are described in supplement 1.
Whole-body cycling performance
For sprint performance, 1-s peak power output (PO peak ) was obtained from a 30-s Wingate test on a bicycle ergometer (Monark 894 E Peak Bike, Monark Exercise AB, Vansbro, Sweden). Subjects received strong verbal encouragement and remained seated throughout the test. Workload was applied after 2 revolutions and was set at 10% body mass. One minute after exercise, blood lactate concentration was obtained from the fingertip (Lactate Pro 2 Arkray KDK, Kyoto, Japan). For endurance performance, we obtained average power output during a 15-km time trial (PO TT ) on an electronically braked bicycle ergometer (VU-MTO, Amsterdam, The Netherlands). Power output was determined from torque and cadence measurements sampled at 100 Hz. Completed cycling distance was calculated as a function of power output, rolling friction (μ r =0.003) and air friction (μ a =0.17), similar to road cycling. Subjects self-selected their preferred gear ratio and received visual and verbal feedback on their time trial progression.
To eliminate the influence of body size and investigate only biological differences in power production (rather than physical principles), physical performance was normalized to (LBM) 2/3 , where LBM is lean body mass 37 . Fat mass was obtained from the sum of 4 skinfolds 39 . How well individual cyclists were able to combine sprint and endurance performance was expressed relative to the whole group. Hereto, combined sprint and endurance performance (PO TT + PO peak ) was assessed by perpendicular residuals to the Deming regression line between PO TT and PO peak , i.e. the perpendicular projections of the data points onto this regression line (see Figure 6 .2). Thus, perpendicular residuals equal the perpendicular distances from individual data points to the Deming regression line, which accounts for error in both variables instead of error in variable y only. These residuals quantify both how much a cyclist's sprint performance differs from his expected sprint performance (i.e. delta between actual sprint performance and predicted sprint performance based on the regression line and the cyclist's actual endurance performance) as well as how much endurance performance differs from his expected endurance performance (i.e. delta between actual endurance performance and predicted endurance performance based on the regression line and the cyclist's actual sprint performance).
Whole-body oxygen consumption
Whole-body V O 2 was obtained during the 15-km time trial and during a maximal incremental exercise test (on a Monark Ergomedic 839E, Monark exercise AB, Sweden), and was recorded breath-by-breath using open circuit spirometry (Cosmed Quark CPET, Cosmed S.R.L., Rome, Italy). Prior to testing, gas analyzer and volume transducer were calibrated according to manufacturer's instructions. Breath-by-breath data was smoothed and then averaged over the time trial to obtain performance V O 2 . V O 2max was calculated as the highest 30-s value and maximal work rate (W max ) as highest 3-min value achieved during the maximum-effort incremental test to voluntary exhaustion. Initial workload was 80W and increased by 40W•3min -1
. Gross efficiency was calculated for the last minute of each increment, dividing mechanical power by oxidative metabolic power, while accounting for power loss within the Monark transmission system 2 . Metabolic power was derived from V O 2 and respiratory exchange ratio (RER) 40 . Highest gross efficiency was obtained with RER <1.0 and V O 2 in steady state (<5% change between min 2-3 of each increment) 40 . V O 2 at ventilatory thresholds (VT1 and VT2) and lactate thresholds (LT1 and LT2) were obtained from 30-s moving averages. VT1 was determined using the V-slope method and ventilatory equivalents 41 were measured with respect to the start of the 15-km time trial using a continuous-wavelength near-infrared spectroscopy device (Portamon, ArtinisMedical Systems, Arnhem, the Netherlands), according to 44 .
Maximal isometric knee-extension torque
Maximal isometric knee-extension (KE) torque of the right leg was measured using a custom-made dynamometer. Active knee flexion angle was set at 60° during submaximal activation, after aligning the subject's anatomical knee axis with the dynamometer rotation axis, and hip flexion angle was set at 85° (full extension equals 0°). The lower leg was protected by a shin guard and strapped to a force transducer (KAP E/200Hz, Bienfait B.V. Haarlem, The Netherlands) placed 26.6 cm distally from the knee joint and subjects were firmly secured with straps over hips and shoulders. After warm-up, subjects performed 4-5 attempts to attain maximal isometric KE torque, receiving online visual feedback on their force tracings. KE torque was obtained after multiplication of measured forces (sampled at 1 kHz) with the lever arm. Maximal isometric KE torque was calculated as highest 100-ms average obtained during the 5-s isometric contractions.
Whole-muscle morphology
Whole-muscle vastus lateralis morphology was examined using 3D ultrasound imaging 45 . Briefly, the hip flexion angle was set at 85° and knee flexion angle at 60°. B-mode ultrasound images were collected at 25 Hz during multiple scans of the right VL using a 5-cm linear probe in longitudinal or transverse orientation (Technos MPX, ESAOTE S.p.A. Italy). Location and orientation of the probe were registered by a motion capture system (Optotrak Certus, NDI, Waterloo, Canada) and synchronized with ultrasound images to construct a 3D voxel array, using customized software (Matlab, Mathworks Co, Natick,Massachusetts, USA). Distal VL muscle belly end and proximal attachment to the trochanter major were identified using 3D image-processing software (Medical Imaging Interaction Toolkit (MITK); www.mitk.org). VL muscle volume was measured between these anatomical landmarks using manual segmentation of the anatomical cross-sections and subsequent interactive interpolation in MITK. Fascicle length (L f ) and pennation angle between fascicle and distal aponeurosis (θ) were assessed within the mid-longitudinal fascicle plane at a position 2/3 rd along the muscle belly (distal from origin). Physiological cross-sectional area (PCSA) was calculated by dividing muscle volume by L f . PCSA was multiplied by cosine θ to provide the effective PCSA 46 . Specific force of the VL was estimated using KE isometric torque, optimal patellar moment arm (d PT ), the contribution of VL to m. quadriceps femoris (QF) and effective PCSA. D PT is very similar between subjects (average 4.7-4.8 cm) 46, 47 and was assumed to be 4.75 cm in all cyclists. As VL volume is ~34% of the total QF volume in cyclists 48 , and this percentage is similar for PCSA and volume 47 , VL specific force was estimated using Equation 6 .1:
Blood sampling
Resting blood samples were collected in EDTA-coated vacutainer tubes (BD Biosciences, Franklin Lakes, NJ, USA) using venipuncture and analyzed for red blood cells (RBC), hemoglobin concentration ([Hb]), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC). Hct was determined by micro-hematocrit analysis.
Muscle biopsy samples
Biopsies were obtained from the right VL as described previously 34 . In brief, muscle biopsies were collected after local anesthesia ~15 cm above the patella at a depth of ~4 cm. Biopsy samples were aligned to muscle fiber arrangement, frozen in liquid nitrogen, and then cut in 10-μm thick sections using a cryostat at -20°C. Sections were collected on polylysine-coated slides and stored at -80°C until further analysis.
Muscle fiber histochemistry
Fiber-type composition was obtained using immunofluorescence analysis of myosin heavy chain (MHC) expression 49 , using primary antibodies BA-D5, SC-71 and 6H1 and secondary antibodies Alexa Fluor 488 IgG2b, 488 IgG1 and 647 IgM (DSHB, Iowa City, IA, USA).
Fiber-type distribution (type I, I/IIA, IIA, IIAX, IIX) was manually determined from 388±142 fibers per subject (mean ± SD).
Mitochondrial oxidative capacity was assessed by succinate dehydrogenase (SDH) activity determined using quantitative histochemistry 50, 51 . SDH activity of the biopsy was determined from absorbance measurements at 660 nm using fiber type distribution and spatially averaged SDH activity, including subsarcolemmal mitochondria, of 51±11 randomly selected fibers (range 36 -79) in ImageJ 34, 52 . SDH activity was used to calculate muscle fiber oxidative capacity (fiber V O 2max , in nmol·mm -3 ·s -1
) and whole-body oxidative capacity, according to 34 . Whole-body oxidative capacity was normalized to LBM 2/3 . Fiber cross-sectional area (FCSA) was determined from fiber type distribution and manually segmented FCSA of 51±11 randomly selected fibers. Fiber circularity was calculated as (4π•FSCA)/ (perimeter) 2 and longitudinally cut fibers were excluded from analysis (i.e. circularity <0.60 in accordance with Ref 53 ). Average circularity was 0.79 ± 0.03. PCSA reflects the cross-sectional area of all fibers, including interstitial space and connective tissue. An estimate of muscle fiber number of the VL was provided by dividing the PCSA (from 3D ultrasound imaging) by average FCSA. Average SDH activity was multiplied by average FCSA to obtain spatially integrated SDH (iSDH activity).
Capillarization was assessed by staining for Ulex Europaeus Agglutinin 1 lectin (UEA-1) (adapted from Ref 54 ). Sections (10 μm) were air-dried, fixed in acetone at -20˚C for 15 min, blocked with 1% bovine serum album for 30 min and incubated at room temperature for 30 min with biotinylated UEA-1 (20 μg•mL -1 , Vector Laboratories, Inc., Burlingame, CA, USA). Subsequently, sections were incubated for 30 min with VECTASTAIN Elite ABC Kit PK-6100 (Vector Laboratories, Inc., Burlingame, CA, USA) and incubated for 30 min with Red Peroxidase Substrate SK-4285 (ImmPACT™ AMEC, Vector Laboratories, Inc., Burlingame, CA, USA). Capillaries were analyzed for capillary-to-fiber ratio (C/F), capillaries around each fiber (CAF) and capillaries per mm 2 muscle tissue (capillary density (CD)). Muscle fibers and capillaries were counted from three photomicrographs of the biopsy section. For C/F ratio, muscle fiber fragments cut by left and upper margins and associated capillaries were rejected and those cut by right and lower margins were included in the analysis. Longitudinally cut capillaries were counted as one at each muscle fiber junction 55 . On average, 265 ± 95 capillaries and 94 ± 35 muscle fibers were analyzed per subject.
Myoglobin (Mb) concentration was determined by calibrated histochemistry using a vapor-fixation technique 52, 56 . Absorbance was measured at 436 nm 52 . Peroxidase activity of haemoglobin was excluded from measurements. Mb concentrations were obtained after calibration using gelatin sections containing known concentrations of horse Mb.
Image analysis
For muscle fiber type analysis, images were captured at ×10 objective using a CCD camera (PCO, Sensicam, Kelheim, Germany) connected to a fluorescence microscope (Axiovert 200M; Zeiss, Göttingen, Germany) and image processing software (Slidebook 5.5; Intelligent Image Innovations, Denver, Colorado). SDH activity and myoglobin images were made at ×10 objective using a Leica DMRB microscope (Wetzlar, Germany) with calibrated grey filters and a CCD camera (Sony XC77CE, Towada, Japan) connected to a LG-3 frame grabber (Scion, Frederick, MD, USA). Capillarization images were collected using a Zeiss AxioCam MRc colour camera connected to a Zeiss Axioskop microscope and image-capture software (Zeiss KS 300 version 3.0, Carl ZeissImaging Solutions GmbH, Germany).
Statistical analysis
Results are expressed as mean±SD. Relationships between normalized sprint and endurance performance, ranked normalized sprint and endurance performance and between fiber size -1 and fiber oxidative capacity were assessed by Deming linear regression analysis. Perpendicular residuals to the Deming regression lines were used to quantify combined sprint and endurance Capillaries were indicated by arrows in one muscle fiber indicating capillaries were more prominent in the Olympic cyclist compared to the amateur road cyclist (E and K). Histochemical assays for myoglobin (F and L) contain black spots due to peroxidase activity of hemoglobin, which was excluded from analysis. Scale bar is 100 μm. performance (PO peak +PO TT ) or the combination of FCSA -1 and fiber V O 2max (FCSA -1 was used to take into account the hyperbolic relationship between these two variables; for details see the section whole-body cycling performance). Coefficients of determination were obtained for normalized sprint, endurance and combined sprint and endurance performance by Pearson's correlations and stepwise multiple regression analysis. Predictors were included in the model if a significant R 2 change (p<0.05) was reported. Results were considered significant if p<0.05. Tendencies were also reported if p<0.10. Table 6 .1 shows values for sprint performance, endurance performance and physiological performance determinants, whereas muscle fiber histochemistry was displayed in Figure 6 .1. The relationship between sprint and endurance performance per kg body mass was inverse (r=-0.44, p<0.05). An even more pronounced inverse relationship was shown between PO peak and PO TT normalized to LBM 2/3 (r=-0.66, p<0.001, Figure 6 .2). Normalized sprint and endurance performance largely differed between cyclists, up to 1.5-fold and 2-fold differences, respectively. Substantial variation between subjects was also observed for combined sprint and endurance performance (PO peak +PO TT ), reflected by perpendicular residuals. The cyclist with the highest PO peak +PO TT was an Olympic track cyclist competing at the highest performance level. These results indicate that the observed variation in (combined) sprint and endurance performance allows further exploration of critical determinants of physical performance. , where LBM is lean body mass, to scale for differences in body mass. Perpendicular distances to the regression line between PO TT and PO peak (i.e. perpendicular residuals) reflected how well individual cyclists were able to combine sprint and endurance performance relative to the whole group (PO TT + PO peak ; see text). Individual data was presented for track sprinters (), team pursuit cyclists (), (inter)national road cyclists () and amateur road cyclists (). B) Normalized sprint and endurance performance were ranked from no. 1-28, and also demonstrated an inverse relationship, as obtained with Deming regression analysis. ), whereas their fascicle lengths were similar (9.6 ± 1.3 cm and 10.1 ± 1.7 cm, respectively). A large PCSA tended to be associated with large pennation angles (r=0.34, p=0.08), whereas a long L f was associated with relatively small pennation angles (r=-0.46, p<0.05). PCSA was related to FCSA of both type I and II fibers (r=0.56, p<0.01 and r=0.74, p<0.001, respectively). In the subgroup of team pursuit and road cyclists, L f and specific force also significantly contributed to normalized sprint performance. Multiple regression analyses showed that percentage fast type fibers and VL muscle volume together explained 65% of variance in normalized PO peak in the whole group, whereas 48% of the variance in normalized PO peak was explained by percentage fast type fibers and L f in the subgroup of team pursuit and road cyclists. These results indicate that the major determinants of normalized sprint performance are a high percentage fast type fibers, large muscle volume and long muscle fibers.
Results
Sprint and endurance performance
Notes:
Determinants of normalized endurance performance
Normalized endurance performance was explained by gross efficiency, performance V O 2 , V O 2max , V O 2LT2 , V O 2VT2 and whole-body oxidative capacity (see Figure 6. Determinants of combined sprint and endurance performance Combined sprint and endurance performance (PO peak +PO TT ) was explained by whole-body performance V O 2 and gross efficiency and showed a tendency with VL volume and L f (p=0.056 and p=0.059, respectively; see Figure 6 .3). Arrangement of L f and PCSA differed between track sprinters and other cyclists (as described above). Therefore, L f may have explained less variance in PO peak +PO TT in the whole group compared to the subgroup of team pursuit and road cyclists (R 2 =0.13 and R 2 =0.25, respectively). In the whole group, 30% of the variance in PO peak +PO TT was explained by gross efficiency and VL volume. In the subgroup of team pursuit and road cyclists, 49% of variance in PO peak +PO TT was explained by performance V O 2 and L f .
Whole-muscle architecture may be important for PO peak +PO TT . L f explained 13-25% of the variance in PO peak +PO TT , whereas PCSA was not related to PO peak +PO TT. Moreover, PCSA negatively affected performance V O 2 (see Equation 6 .2), which was a main determinant of combined sprint and endurance performance. These results suggest that for VL, a long L f rather than a large PCSA is likely beneficial for obtaining a high combined sprint and endurance performance.
Muscle fiber CSA and muscle fiber V O 2max were studied in more detail. These showed an inverse hyperbolic relationship (r=-0.50, p<0.01, see Figure 6 .4), which illustrates that it is difficult to simultaneously obtain a large FCSA and high muscle fiber V O 2max . How well the cyclists combined a large fiber size with a high oxidative capacity was assessed in absolute terms and relative to the group, i.e. by the product of FCSA and fiber V O 2max (iSDH activity) and by perpendicular residuals of FCSA and fiber V O 2max , respectively (see Figure 6 .4). It was theoretically expected that high muscle fiber oxygen demands (i.e. high iSDH activity or high residuals) were matched by enhanced oxygen supply capacity towards and within the muscle fiber. Our results show that iSDH activity was indeed positively related to capillarization (C/F: r=0.58, p<0.001 and CAF: r=0.53, p<0. Normalized sprint and endurance performance as well as FCSA and fiber V O 2max were inversely related (see Figures 6.2 and 6.4) . Perpendicular residuals of both regression lines were, however, not related (see Table 6 .2). This finding may relate to muscle fiber number, as athletes with many muscle fibers have less need for combining high FCSA and fiber V O 2max : muscle fiber number was negatively related to perpendicular residuals of FCSA and fiber V O 2max (r=-0.41, p<0.05). Perpendicular residuals showed a positive relationship with endurance performance, performance V O 2 , V O 2max , V O 2 at lactate and ventilatory thresholds and a tendency with gross efficiency (see Table 6 .2). Therefore, combining high FCSA and fiber V O 2max did not directly relate to high PO peak +PO TT , likely due to muscle fiber number, but was associated with enhanced (determinants of ) endurance performance.
Discussion
This study integrates physiological performance determinants at different biological levels, from cell to whole-body, to obtain insights in the critical determinants of normalized sprint, endurance and combined sprint and endurance performance. We show that percentage fast type fibers and muscle volume explain 65% of the variance in normalized sprint performance and that , where LBM is lean body mass. Combined sprint and endurance performance (PO peak +PO TT ) was reflected by perpendicular residuals of the regression line between PO peak and PO TT (see Figure 6 .1). Bars indicate significant determinants of (combined) sprint and endurance performance in cyclists and their explained variance (r 2 in %) obtained from Pearson correlations. Black bars indicate significant determinants (p<0.05) and grey bars indicate a tendency (p<0.10). White bars (and *) illustrate significant determinants (p<0.05) in a subgroup of team pursuit and road cyclists. Multiple regression analyses revealed a combination of predictors, which were presented at the bottom of each panel. Muscle determinants were obtained from the VL. Abbreviations: PO peak , sprint performance; PO TT , endurance performance; PO peak +PO TT , combined sprint and endurance performance; KE, knee extension; Specific force, F/PCSA or knee extension force per physiological cross-sectional area; PCSA, physiological cross-sectional area; L f , fascicle length; [Lactate] The results indicate that for VL, a long fascicle rather than a large PCSA is likely beneficial for achieving high PO peak +PO TT . Though normalized sprint and endurance performance as well as muscle fiber size and muscle fiber oxidative capacity were inversely related, cyclists succeeded to combine relatively large FCSA and high fiber V O 2max with enhanced capillarization.
Physiology of sprinters: high normalized sprint performance requires long and fast muscle fibers
We show that VL muscle volume and percentage fast type fibers explain 65% of the variance in normalized PO peak . This finding was not unexpected, as previous data demonstrated that both muscle volume and fiber-type distribution are important for cycling peak power production 11 . Peak power output during cycling could be predicted by lean body mass 16 , lean leg volume 16, 30 and lean thigh volume 57 . Certainly, increases in muscle mass will improve peak power production by the muscle, irrespective of its fiber-type distribution. The proportion of fast type fibers is also critical to peak power production, as it determines maximal muscle fiber contraction velocity 27, 58, 59 . Optimal pedaling velocity during sprint cycling has been shown to relate to the proportion of fast type fibers in m. vastus lateralis 30 and their proportion of the cross-sectional area 31 . In line with the data above, the product of lean thigh volume and optimal pedaling rate (i.e. proxy measure for fiber-type distribution) explained 83% of the variance in maximal power across the life span (from 8 to 70 years) 29 . Although sprint performance was normalized to LBM 2/3 to remove the influence of body size, muscle volume was still a significant predictor of normalized PO peak . This may indicate that large VL volume also contributes to biological differences in power production, possibly by distributing muscle mass towards locomotory muscles or by increasing the percentage of muscle mass. Proportion fast type fibers is also associated with anaerobic energy production. Lactic acid production explains a large proportion of variance in sprint performance, accounting for ~half of energy demands during a Wingate 60 . Although blood lactate concentration was higher in our track sprinters (17.1 ± 1.9 mmol•L -1 ) compared to team pursuit and road cyclists (14.2 ± 2.5 mmol•L -1 ), it explained only 17% of normalized PO peak , likely because it only reflects part of the total lactate production 61, 62 . The results confirm that percentage fast type fibers and VL muscle volume were the critical determinants of normalized sprint performance.
The question is whether VL muscle architecture influences normalized sprint performance. Arrangement of PCSA and L f differed between the track sprinters and other cyclists, revealing a much larger PCSA but similar L f in the track sprinters. A long fascicle length (i.e. high numbers of sarcomeres in-series) has theoretically been associated with high maximal muscle fiber contraction velocity 63 and has been shown to relate to better sprint performance 14, 15 . PCSA is increased by muscle fiber hypertrophy and is thought to result in proportional increases in maximal muscle force 27, 64 , assuming that specific force (F•PCSA -1 ) remains constant. However, knee-extensor specific force in our track sprinters (30 ± 7 N•cm -2 ) was lower than that of the other cyclists (38 ± 7 N•cm -2 ), and similar to that of healthy males 46 . Specific force of track sprinters may have been reduced because their larger PCSA showed a tendency with larger pennation angles, reducing force exertion with respect to the line of pull 65 . These findings may also explain why peak power per kg body mass of our track sprinters was lower than that of elite track sprinters (18 [66] [67] [68] , even though absolute sprint performance was similar (1592 ± 95 W) 66, 67 . Results show that an optimal normalized sprint performance requires fast muscle fibers, a large muscle volume, and muscle architecture with long L f rather than a large PCSA. , we assessed how whole-body performance V O 2 was explained by oxygen demand and oxygen supply within the muscle. To the best of our knowledge, our study is the first to show that variance in performance V O 2 is explained by muscle fiber oxidative capacity, oxygen supply capacity towards and within the muscle fiber ([Mb]•C/F) and physiological cross-sectional area of the muscle (R 2 =0.67). These results suggest matching between O 2 supply and demand at the muscle fiber level (Q O 2 /V O 2 matching) and demonstrate the detrimental effect of muscle hypertrophy (i.e. increase in PCSA) on average oxygen consumption during the endurance performance. The importance of Q O 2 /V O 2 matching is also indicated by a higher [O 2 HbMb] concentration during the time trial, reflecting a lower oxygen extraction. High normalized endurance performance requires matching of O 2 demand and O 2 supply, preferably with a small PCSA.
Physiology of endurance cyclists
Gross efficiency explained 36% of the variance in normalized PO TT and was associated with high percentage slow type fibers, similar to previous observations in competitive cyclists 69 . Maximal efficiency of type I and type IIA fibers are similar 70 , however, type I fibers attain their peak efficiency at lower shortening velocities 70 . Accordingly, it has been suggested that a large proportion of slow type fibers results in a higher efficiency at common cycling cadences (i.e. 60-120 rpm) 1 . Gross efficiency was also associated with C/F and CAF. Note that gross efficiency was not obtained at fixed exercise intensity, but at an exercise intensity just below LT2 (77±8% V O 2max ). When controlled for exercise intensity, partial correlation analyses show that significant correlations disappear between gross efficiency and C/F, CAF or fiber type, suggesting that capillarization and fiber type allow steady state O 2 consumptions at higher exercise intensities and indirectly influence gross efficiency. Future studies are warranted to investigate determinants of gross efficiency in more detail.
Limiting factors for optimal combined sprint and endurance performance First, we discuss findings at the muscle fiber level. Second, we discuss integration of determinants for combined sprint and endurance performance. Fiber size and fiber oxidative capacity were previously reported to be inversely related across and within animal species 25, 35 . The present study shows a similar inverse hyperbolic relationship in human athletes (r=-0.50). Such an inverse relationship between FCSA and fV O 2max is likely explained by matching of muscle fiber oxygen demand and supply. Hill-type model predictions show that increases in oxygen demand (iSDH activity=FCSA×fV O 2max ) may occur, but only when accompanied by improved oxygen diffusion from capillary blood to the core of the muscle fiber 25 . The oxygen diffusion depends on the solubility of oxygen in muscle, diffusion coefficient for oxygen in sarcoplasm, interstitial oxygen tension (PO 2 ) and the concentration of intracellular oxygen carrier myoglobin 71, 72 . If oxygen Chapter 6 118 demand exceeds oxygen supply, the muscle fiber will become hypoxic. Enhanced oxygen supply may accommodate sustained increases in oxygen demand (iSDH activity), by elevating interstitial PO 2 to prevent the center of the muscle fiber from becoming hypoxic at V O 2max . Of note, lactic acid production from glycolytic ATP synthesis also occurs without cellular hypoxia, for instance at the start of exercise, when phosphate and ADP concentrations are low and mitochondria do not synthesize ATP at their full oxidative capacity. To the best of our knowledge, it has never been tested whether and to what extent trained humans are able to increase iSDH activity values. This study shows that athletes succeeded to obtain much higher iSDH activity values (0.147 ± 0.034 in ∆A660•μm•s -1 ) than untrained humans (0.087 ± 0.004) 50 or heart failure patients (0.048 ± 0.004) 50 . So, even though muscle fiber size and oxidative capacity were inversely related, athletes were able to obtain high iSDH activity values.
How well cyclists are able to combine relatively large FCSA with high oxidative capacity was assessed in absolute terms and relative to the group, i.e. by iSDH activity and perpendicular residuals of FCSA and fiber V O 2max , respectively. It was expected that high oxygen demands (high iSDH activity or high residuals) were matched by enhanced oxygen supply, due to 1) enhanced oxygen supply towards the muscle fiber 2) enhanced oxygen supply within the muscle fiber, or 3) relocating mitochondria to the sarcolemma 25 . Firstly, our results show that iSDH activity and residuals were positively associated with capillarization (C/F and CAF) and likely MCV, facilitating a higher interstitial PO 2 , reflected by higher [O 2 HbMb] values. Surprisingly, both iSDH activity and residuals did not relate to RBC, [Hb] and Hct, possibly due to methodological considerations (i.e. measures depend on solution of the venous sample) or because these measures neglect differences in blood flow or blood volume 73 . Secondly, Mb concentration was not associated with iSDH activity or residuals (p=0. 16 and p=0.23, respectively) . This could be due to the small variation in [Mb] between cyclists (coefficient of variation ~10%). Thirdly, visual inspection of staining for SDH activity indicated high subsarcolemmal SDH activities, particularly in type I fibers (see Figure 6 .1). High combinations of muscle fiber size and fiber oxidative capacity were associated with enhanced O 2 supply towards the muscle fiber, but not within the muscle fiber.
This study shows that combined sprint and endurance performance of cyclists is associated with gross efficiency, performance V O 2 , and likely with VL muscle volume and fascicle length (see Figure 6 .5). Performance V O 2 is explained by matching of O 2 demand and O 2 supply, preferably by a small PCSA (see Equation 6 .2). These findings illustrate that a long fascicle rather than a large PCSA is beneficial for achieving high PO peak +PO TT , thereby avoiding the inverse relationship between FCSA and fiber V O 2max . Though FCSA and fiber V O 2max as well as normalized sprint and endurance performance were inversely related (see Figure 6 .2 and 6.4), their residuals were not related. Both PO peak +PO TT and combined FCSA and fiber V O 2max incorporate prediction errors associated with their regression line, which may explain the non-significant correlation. In addition, muscle fiber number was negatively related to the residuals of FCSA and fiber V O 2max , suggesting that subjects with a large number of muscle fibers have less need for combining a high FCSA and fiber V O 2max to develop high combined sprint and endurance performance: they will achieve a given PCSA with smaller muscle FCSA. Muscle fiber number is determined early in life, because hyperplasia does not occur in mature mammalian skeletal muscle 27, 74 . Although residuals of FCSA and fiber V O 2max were not related to PO peak +PO TT , these residuals were associated with better endurance performance, performance V O 2 and showed a tendency with gross efficiency, which are all determinants of PO peak +PO TT . Percentage fast type fibers did not determine PO peak +PO TT , likely because it was positively related to normalized PO peak , but negatively related to normalized PO TT . In summary, high combined sprint and endurance performance is associated with a high gross efficiency, large muscle volume, a muscle architecture characterized by a small PCSA and long fascicles and matching of oxidative capacity and oxygen supply capacity, preferably by well-developed capillarization. 
Implications
Based on the present results, key physiological determinants serve as targets for training strategies in sports such as cycling to optimize sprint and endurance performance. Athletes are encouraged to incorporate endurance training and resistance training that target improvement of gross efficiency, oxidative capacity and oxygen supply capacity, and muscle volume with increases in muscle fiber length rather than muscle fiber hypertrophy. Small, but limited increases in muscle fiber size are possible, but should be accompanied by enhanced capillarization to improve both FCSA and fiber V O 2max simultaneously. Certainly, coaches and athletes evaluate the distance at which the athlete excels. Nevertheless, the Wingate test and time trial provide generic measures for athletes of all disciplines to assess their combined sprint and endurance performance and characterize them within the sprint-endurance continuum. These two tests also allow time-efficient identification of new talent and help these talents to tune into their preferred sports discipline. The comprehensive physiological profile reveals the athlete's physiological strengths and weaknesses with respect to their sport-specific discipline, which is key to talent development, designing individualized training strategies and monitoring the progress of training interventions.
To optimize both sprint and endurance performance, future studies are warranted to investigate longitudinal effects of combined resistance and endurance training on critical physiological determinants and physical performance. Training strategies to improve cycling efficiency may include heavy or explosive resistance training 75 , but gross efficiency may also benefit from enhanced capillarization. Angiogenesis is induced by upregulation of the vascular Figure 6 .5. Physiological determinants of normalized sprint, endurance and combined sprint and endurance performance. Proportion fast type fibers, fascicle length and VL muscle volume explain variance in normalized sprint performance, whereas performance V O 2 , oxygen supply within the circulation (MCHC and O 2 HbMb), and gross efficiency explain variance in normalized endurance performance. Combined sprint and endurance performance was explained by gross efficiency, performance V O 2 and likely by VL volume and L f . Performance V O 2 is explained by a high muscle fiber oxidative capacity, high oxygen supply capacity towards and within the muscle fiber ([Mb]•C/F) as well as small muscle's physiological cross-sectional area. At the muscle fiber level, fiber size and fiber oxidative capacity were inversely related, similar to the inverse relationship between normalized sprint and endurance performance. Several cyclists succeeded to combine high FCSA and fiber V O 2max with enhanced capillarization, whereas subjects with a large number of muscle fibers have less need for combining a high FCSA and fiber V O 2max . These results suggest that fascicle length and capillarization may be important targets for individualized training strategies to optimize both sprint and endurance performance. endothelial growth factor (VEGF), which occurs with exercise (for review see Ref 76 ), especially during high-intensity training in hypoxic conditions 77 . High-intensity training in hypoxia also increases mRNA expression of myoglobin 77 , likely due to local tissue hypoxia within the muscle. However, hypoxia also attenuates the rate of translation and may result in muscle atrophy (for review see Ref 78 ). Endurance exercise stimulates markers for mitochondrial biogenesis, but inhibits activation of mTOR, which reduces muscle protein synthesis and muscle fiber hypertrophy [24] [25] [26] . Phosphorylation of mTOR inhibits activation of myoglobin mRNA expression 79 . It may be beneficial focus on lengthening of muscle fibers (i.e. addition of sarcomeres in-series), possibly with plyometric training or eccentric resistance training 80, 81 . Increases in L f enhance sprint performance, whereas these may not negatively affect fiber V O 2max necessary for a high endurance performance. Therefore, skeletal muscle adaptations for the optimal combination of both sprint and endurance performance appear to be complex, and require sophisticated modulation of training intensity, timing and mode in an individualized training strategy.
Limitations
This cross-sectional study reveals critical determinants of physical performance (see Figure 6 .5), but did not describe longitudinal effects of resistance or endurance training on these determinants. Muscle volume arrangement into PCSA and L f was likely suboptimal in our track sprinters and may have increased unexplained variance in performance. Additional variance may have been explained by physiological determinants that were not measured, such as heart pumping capacity, lung diffusion and ventilation capacity, neuromuscular recruitment (i.e. firing frequency, synchronization, agonist-antagonist activity), muscle metabolites (e.g. phosphocreatine, muscle lactate, inosine 5'-monophosphate (IMP)), muscle tendon moment arm, tendon elasticity or glycogen availability. These variables may explain additional variance in combined sprint and endurance performance, whereas assessed physiological determinants already explained a large proportion of variance in endurance and sprint performance in the present study.
Conclusion
This study integrates physiological performance determinants from single muscle fibers to whole-body biological levels and shows that normalized sprint performance was explained by percentage fast type fibers, fascicle length and muscle volume of the vastus lateralis. Performance V O 2 and oxygen supply within the circulation (MCHC and [O 2 HbMb]) critically determined normalized endurance performance. Combined sprint and endurance performance was explained by gross efficiency, performance V O 2 (i.e. high oxidative capacity, a well-developed oxygen supply capacity and small PCSA) and likely by VL volume and L f . The results suggest that, in sports such as cycling, fascicle length and capillarization may be important training targets to optimize sprint and endurance performance simultaneously. Training specifics of all cyclists and of the specific subgroups, including training frequency, training duration, cycling distance and training experience. Training cycling distance was somewhat lower in (inter)national road cyclists, as some of the road cyclists were involved in triathlon or duathlon.
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